Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-032212
Filing Date
2023-09-13
Accepted
2023-09-13 17:18:34
Documents
58
Period of Report
2023-07-31

Document Format Files

Seq Description Document Type Size
1 10-Q csbr-20230731.htm   iXBRL 10-Q 628096
2 EX-31.1 csbrq1731202310-qex311.htm EX-31.1 10784
3 EX-31.2 csbrq1731202310-qex312.htm EX-31.2 10884
4 EX-32.1 csbrq1731202310-qex321.htm EX-32.1 7921
  Complete submission text file 0001628280-23-032212.txt   3973464

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT csbr-20230731.xsd EX-101.SCH 31612
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT csbr-20230731_cal.xml EX-101.CAL 44792
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT csbr-20230731_def.xml EX-101.DEF 133949
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT csbr-20230731_lab.xml EX-101.LAB 429462
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT csbr-20230731_pre.xml EX-101.PRE 260974
52 EXTRACTED XBRL INSTANCE DOCUMENT csbr-20230731_htm.xml XML 452286
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Filer) CIK: 0000771856 (see all company filings)

EIN.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 001-11504 | Film No.: 231253501
SIC: 2836 Biological Products, (No Diagnostic Substances)